ACERUS PHARMACEUTICALS Revenue vs. Price to Book

For ACERUS PHARMACEUTICALS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ACERUS PHARMACEUTICALS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ACERUS PHARMACEUTICALS CORP utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ACERUS PHARMACEUTICALS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ACERUS PHARMACEUTICALS CORP over time as well as its relative position and ranking within its peers. Check out Trending Equities.

ACERUS Current Profitability Trends 

 
Refresh
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ACERUS PHARMACEUTICALS Price to Book vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ACERUS PHARMACEUTICALS's current stock value. Our valuation model uses many indicators to compare ACERUS PHARMACEUTICALS value to that of its competitors to determine the firm's financial worth.
ACERUS PHARMACEUTICALS CORP is the top company in revenue category among related companies. It is number one stock in price to book category among related companies . The ratio of Revenue to Price to Book for ACERUS PHARMACEUTICALS CORP is about  119,540 

ACERUS Revenue vs. Competition

ACERUS PHARMACEUTICALS CORP is the top company in revenue category among related companies. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 3.12 Million. ACERUS PHARMACEUTICALS totals roughly 1.56 Million in revenue claiming about 50% of equities under Drug Manufacturers—Specialty & Generic industry.

ACERUS Price to Book vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
ACERUS PHARMACEUTICALS 
Revenue 
 = 
Money Received 
Discounts and Returns 
1.56 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
ACERUS PHARMACEUTICALS 
P/B 
 = 
MV Per Share 
BV Per Share 
13.05 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

ACERUS PHARMACEUTICALS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ACERUS PHARMACEUTICALS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ACERUS PHARMACEUTICALS will eventually generate negative long term returns. The profitability progress is the general direction of ACERUS PHARMACEUTICALS's change in net profit over the period of time. It can combine multiple indicators of ACERUS PHARMACEUTICALS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ACERUS PHARMACEUTICALS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ACERUS PHARMACEUTICALS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ACERUS PHARMACEUTICALS's important profitability drivers and their relationship over time.

Use ACERUS PHARMACEUTICALS in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACERUS PHARMACEUTICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACERUS PHARMACEUTICALS will appreciate offsetting losses from the drop in the long position's value.

ACERUS PHARMACEUTICALS Pair Trading

ACERUS PHARMACEUTICALS CORP Pair Trading Analysis

Correlation analysis and pair trading evaluation for Denbury Resources, and Western Midstream. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your ACERUS PHARMACEUTICALS position

In addition to having ACERUS PHARMACEUTICALS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate
Real Estate Theme
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. Real Estate theme has 30 constituents.
View All  Next Launch Real Estate
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
To fully project ACERUS PHARMACEUTICALS's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ACERUS PHARMACEUTICALS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ACERUS PHARMACEUTICALS's income statement, its balance sheet, and the statement of cash flows.
Potential ACERUS PHARMACEUTICALS investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ACERUS PHARMACEUTICALS investors may work on each financial statement separately, they are all related. The changes in ACERUS PHARMACEUTICALS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ACERUS PHARMACEUTICALS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.